Endocrinology, Diabetes and Metabolism Case Reports
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 0.9 | Q4 | 13.0% | 0.306 | Q3 | 44.2% |
| 2024 | 0.7 | Q4 | 10.9% | 0.289 | Q3 | 44.5% |
| 2023 | 0.7 | Q4 | 15.4% | 0.280 | Q3 | 46.7% |
| 2022 | 0.9 | 15.9% | 0.282 | Q3 | 48.7% | |
| 2021 | — | 27.0% | 0.289 | Q3 | 50.3% | |
| 2020 | — | — | 0.307 | Q3 | 51.2% | |
| 2019 | — | — | 0.426 | Q3 | 62.8% | |
| 2018 | — | — | 0.744 | Q2 | 76.7% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2052-0573
country
GBcoverage
2014-2016, 2018-2026